Effects of diabetes mellitus on hepatocyte nuclear factor 1 decrease albumin gene transcription

被引:18
作者
BarreraHernandez, G
Wanke, IE
Wong, NCW
机构
[1] UNIV CALGARY,DEPT MED,CALGARY,AB T2N 4N1,CANADA
[2] UNIV CALGARY,DEPT MED BIOCHEM,CALGARY,AB T2N 4N1,CANADA
关键词
D O I
10.1074/jbc.271.17.9969
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have previously reported that albumin gene transcription is reduced in diabetes mellitus (DM), The present study explored the mechanism by which albumin gene transcription is down-regulated in DM. Deletional studies and displacement of factors binding to site B of the albumin promoter indicated that the repressive effects of DM are mediated by nuclear factors binding to this site. Since hepatocyte nuclear factor 1 (HNF1) activates albumin promoter activity and is the predominant factor binding to site B, we examined HNF1. The abundance and binding activity of HNF1 were reduced in hepatonuclear extracts from diabetic compared to control rats, However, HNF1 mRNA levels were unchanged, suggesting that the effect of DM on HNF1 is at the posttranscriptional level. Extracts from diabetic animals also contained another protein, distinct from HNF1 and vHNF1, which bound to site B in gel retardation studies, In summary, our studies demonstrate that the reduced abundance and binding activity of HNF1 correlates with decreased albumin gene transcription in DM.
引用
收藏
页码:9969 / 9975
页数:7
相关论文
共 67 条
  • [1] A VARIANT NUCLEAR-PROTEIN IN DEDIFFERENTIATED HEPATOMA-CELLS BINDS TO THE SAME FUNCTIONAL SEQUENCES IN THE BETA-FIBRINOGEN GENE PROMOTER AS HNF-1
    BAUMHUETER, S
    COURTOIS, G
    CRABTREE, GR
    [J]. EMBO JOURNAL, 1988, 7 (08) : 2485 - 2493
  • [2] CELL-SPECIFIC EXPRESSION OF CYTOSOLIC PHOSPHOENOLPYRUVATE CARBOXYKINASE IN TRANSGENIC MICE
    BEALE, EG
    CLOUTHIER, DE
    HAMMER, RE
    [J]. FASEB JOURNAL, 1992, 6 (15) : 3330 - 3337
  • [3] FUNCTIONAL-ANALYSIS OF DEVELOPMENTALLY REGULATED CHROMATIN-HYPERSENSITIVE DOMAINS CARRYING THE ALPHA-1-FETOPROTEIN GENE PROMOTER AND THE ALBUMIN ALPHA-1-FETOPROTEIN INTERGENIC ENHANCER
    BERNIER, D
    THOMASSIN, H
    ALLARD, D
    GUERTIN, M
    HAMEL, D
    BLAQUIERE, M
    BEAUCHEMIN, M
    LARUE, H
    ESTABLEPUIG, M
    BELANGER, L
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (03) : 1619 - 1633
  • [4] INSULIN INHIBITS LIVER EXPRESSION OF THE CCAAT/ENHANCER-BINDING PROTEIN-BETA
    BOSCH, F
    SABATER, J
    VALERA, A
    [J]. DIABETES, 1995, 44 (03) : 267 - 271
  • [5] ALTERED ISLET AMYLOID POLYPEPTIDE (AMYLIN) GENE-EXPRESSION IN RAT MODELS OF DIABETES
    BRETHERTONWATT, D
    GHATEI, MA
    BLOOM, SR
    JAMAL, H
    FERRIER, GJM
    GIRGIS, SI
    LEGON, S
    [J]. DIABETOLOGIA, 1989, 32 (12) : 881 - 883
  • [6] BURKE PA, 1994, SURGERY, V116, P285
  • [7] COAGULATION AND FIBRINOLYTIC SYSTEM IMPAIRMENT IN INSULIN-DEPENDENT DIABETES-MELLITUS
    CARMASSI, F
    MORALE, M
    PUCCETTI, R
    DENEGRI, F
    MONZANI, F
    NAVALESI, R
    MARIANI, G
    [J]. THROMBOSIS RESEARCH, 1992, 67 (06) : 643 - 654
  • [8] CEREGHINI S, 1992, DEVELOPMENT, V116, P783
  • [9] A LIVER-SPECIFIC FACTOR ESSENTIAL FOR ALBUMIN TRANSCRIPTION DIFFERS BETWEEN DIFFERENTIATED AND DEDIFFERENTIATED RAT HEPATOMA-CELLS
    CEREGHINI, S
    BLUMENFELD, M
    YANIV, M
    [J]. GENES & DEVELOPMENT, 1988, 2 (08) : 957 - 974
  • [10] HEPATOCYTE DEDIFFERENTIATION AND EXTINCTION IS ACCOMPANIED BY A BLOCK IN THE SYNTHESIS OF MESSENGER-RNA CODING FOR THE TRANSCRIPTION FACTOR HNF1/LFB1
    CEREGHINI, S
    YANIV, M
    CORTESE, R
    [J]. EMBO JOURNAL, 1990, 9 (07) : 2257 - 2263